Journal article icon

Journal article

Impaired striatal glutathione–ascorbate metabolism induces transient dopamine increase and motor dysfunction

Abstract:
Identifying initial triggering events in neurodegenerative disorders is critical to developing preventive therapies. In Huntington’s disease (HD), hyperdopaminergia—probably triggered by the dysfunction of the most affected neurons, indirect pathway spiny projection neurons (iSPNs)—is believed to induce hyperkinesia, an early stage HD symptom. However, how this change arises and contributes to HD pathogenesis is unclear. Here, we demonstrate that genetic disruption of iSPNs function by Ntrk2/Trkb deletion in mice results in increased striatal dopamine and midbrain dopaminergic neurons, preceding hyperkinetic dysfunction. Transcriptomic analysis of iSPNs at the pre-symptomatic stage showed de-regulation of metabolic pathways, including upregulation of Gsto2, encoding glutathione S-transferase omega-2 (GSTO2). Selectively reducing Gsto2 in iSPNs in vivo effectively prevented dopaminergic dysfunction and halted the onset and progression of hyperkinetic symptoms. This study uncovers a functional link between altered iSPN BDNF-TrkB signalling, glutathione–ascorbate metabolism and hyperdopaminergic state, underscoring the vital role of GSTO2 in maintaining dopamine balance.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1038/s42255-024-01155-z

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
ORCID:
0000-0002-5514-0364
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
ORCID:
0000-0002-3064-5462
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
ORCID:
0000-0003-0748-8232
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
Weatherall Inst of Molecular Medicine
Role:
Author


More from this funder
Funder identifier:
https://ror.org/052gg0110
Funding agency for:
Minichiello, L
Grant:
ISSF-2019
Programme:
Institutional Strategic Support Fund
More from this funder
Funder identifier:
https://ror.org/02wdwnk04
Funding agency for:
Timm, KN
Grant:
RE/18/3/34214
More from this funder
Funder identifier:
https://ror.org/03x94j517
Funding agency for:
Minichiello, L
Bergin, D
Magill, PJ
Nerlov, C
Grant:
MR/W005166/1
MC_UU_00003/5
MC_UU_12009/7
More from this funder
Funder identifier:
https://ror.org/04atp4p48
Funding agency for:
Guo, F
Grant:
201608060286
More from this funder
Funder identifier:
https://ror.org/051x4wh35
Funding agency for:
Malik, MY
Grant:
INCS-2019-225


Publisher:
Springer Nature
Journal:
Nature Metabolism More from this journal
Volume:
6
Issue:
11
Pages:
2100-2117
Publication date:
2024-10-28
Acceptance date:
2024-09-30
DOI:
EISSN:
2522-5812
ISSN:
2522-5812


Language:
English
Pubs id:
2054086
Local pid:
pubs:2054086
Deposit date:
2024-11-01

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP